ELI LILLY & Co — Director's Dealing 2025

Sep 19, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ELI LILLY & Co (LLY)
CIK: 0000059478
Period of Report: 2025-09-18

Reporting Person: LILLY ENDOWMENT INC (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-09-18	Common Stock	S	39863	$763.292	Disposed	95697115	Direct
2025-09-18	Common Stock	S	23067	$764.519	Disposed	95674048	Direct
2025-09-18	Common Stock	S	26647	$765.567	Disposed	95647401	Direct
2025-09-18	Common Stock	S	13135	$766.451	Disposed	95634266	Direct
2025-09-18	Common Stock	S	3914	$767.065	Disposed	95630352	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $763.00 to $763.9993, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1), (2), (3), (4), and (5) to this Form 4.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $764.00 to $764.9996, inclusive.

F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $765.00 to $765.9883, inclusive.

F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $766.00 to $766.9989, inclusive.

F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $767.00 to $767.5958, inclusive.